Theracurmin Supplementation May be a Therapeutic Option for Older Patients with Alzheimer's Disease: A 6-Month Retrospective Follow-Up Study.

DOST F. S., KAYA D., Ontan M. S., ERKEN N., Bulut E. A., Aydin A. E., ...Daha Fazla

Current Alzheimer research, cilt.18, sa.14, ss.1087-1092, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 14
  • Basım Tarihi: 2021
  • Doi Numarası: 10.2174/1567205019666211221125255
  • Dergi Adı: Current Alzheimer research
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Abstracts in Social Gerontology, Chemical Abstracts Core, EMBASE, MEDLINE, Psycinfo
  • Sayfa Sayıları: ss.1087-1092
  • Anahtar Kelimeler: Acetylcholinesterase inhibitors, Alzheimer's disease, elderly, theracurmin, curcumin, mild cognitive impairment
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background: Alzheimer's Disease (AD) is still a great global challenge and agents with various mechanisms represent a promising therapeutic opportunity. Theracurmin, a very highly absorbable curcumin formulation, was shown to improve memory and attention in non-demented people.